Inactive

The Office of the Biomedical Advanced Research and Development Authority within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (H... The Office of the Biomedical Advanced Research and Development Authority within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) intends to use Project BioShield (PBS) to support to the procurement of an intranasal nalmefene drug-device combination product for use by adult and pediatric populations for the treatment of opioid, including fentanyl overdose. Please see attached solicitation. Amendment 1 provides responses to vendor questions.

Inactive

The Office of the Biomedical Advanced Research and Development Authority within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (H... The Office of the Biomedical Advanced Research and Development Authority within the Administration for Strategic Preparedness and Response (ASPR) at the U.S. Department of Health and Human Services (HHS) intends to use Project BioShield (PBS) to support to the procurement of an intranasal nalmefene drug-device combination product for use by adult and pediatric populations for the treatment of opioid, including fentanyl overdose. PLEASE SEE ATTACHED PRESOLICITATION NOTICE FOR FULL DESCRIPTION.